These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 27600865)

  • 21. Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial.
    Rehal A; Benkő Z; De Paco Matallana C; Syngelaki A; Janga D; Cicero S; Akolekar R; Singh M; Chaveeva P; Burgos J; Molina FS; Savvidou M; De La Calle M; Persico N; Quezada Rojas MS; Sau A; Greco E; O'Gorman N; Plasencia W; Pereira S; Jani JC; Valino N; Del Mar Gil M; Maclagan K; Wright A; Wright D; Nicolaides KH
    Am J Obstet Gynecol; 2021 Jan; 224(1):86.e1-86.e19. PubMed ID: 32598909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of vaginal progesterone to prevent preterm birth in singleton pregnant women with a short cervix at 18-32 weeks gestation.
    Wang X; Maerdan M; Xi J; Zhang M; Yang H; Shi C
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2412751. PubMed ID: 39406681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical Pessary and Vaginal Progesterone in Twin Pregnancies With a Short Cervix.
    Fox NS; Gupta S; Lam-Rachlin J; Rebarber A; Klauser CK; Saltzman DH
    Obstet Gynecol; 2016 Apr; 127(4):625-630. PubMed ID: 26959202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
    Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
    Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of different progesterone preparations with preterm birth prevention.
    Krispin E; Hadar E; Chen R; Wiznitzer A; Kaplan B
    J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3452-3457. PubMed ID: 29699436
    [No Abstract]   [Full Text] [Related]  

  • 26. Cervical pessary plus vaginal progesterone versus long-term tocolysis for the prevention of preterm birth: An observational retrospective study.
    Tajima M; Yanazume S; Orita Y; Tazaki Y; Shinya M; Kobayashi H
    Int J Gynaecol Obstet; 2020 Aug; 150(2):206-212. PubMed ID: 32282943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal cervical length screening in singleton gestations without a previous preterm birth: ten reasons why it should be implemented.
    Khalifeh A; Berghella V
    Am J Obstet Gynecol; 2016 May; 214(5):603.e1-5. PubMed ID: 26707072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of the cervical pessary combined with vaginal progesterone for the prevention of spontaneous preterm birth.
    Daskalakis G; Zacharakis D; Theodora M; Antsaklis P; Papantoniou N; Loutradis D; Antsaklis A
    J Perinat Med; 2018 Jul; 46(5):531-537. PubMed ID: 29055173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine second trimester cervical length screening in low risk women identified women at risk of a 'very' preterm birth but did not reduce the preterm birth rate: a randomised study from India.
    Mishra S; Bagga R; Kalra J; Jain V; Dutta S
    J Obstet Gynaecol; 2018 Aug; 38(6):789-795. PubMed ID: 29537316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes): Guidelines for clinical practice - Text of the Guidelines (short text)].
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1446-1456. PubMed ID: 27836377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined treatment with cervical pessary and vaginal progesterone for the prevention of preterm birth: A randomized clinical trial.
    Karbasian N; Sheikh M; Pirjani R; Hazrati S; Tara F; Hantoushzadeh S
    J Obstet Gynaecol Res; 2016 Dec; 42(12):1673-1679. PubMed ID: 27718280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of spontaneous preterm birth: Guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF).
    Sentilhes L; Sénat MV; Ancel PY; Azria E; Benoist G; Blanc J; Brabant G; Bretelle F; Brun S; Doret M; Ducroux-Schouwey C; Evrard A; Kayem G; Maisonneuve E; Marcellin L; Marret S; Mottet N; Paysant S; Riethmuller D; Rozenberg P; Schmitz T; Torchin H; Langer B
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():217-224. PubMed ID: 28068594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal progesterone in women with twin gestations complicated by short cervix: a retrospective cohort study.
    Brubaker SG; Pessel C; Zork N; Gyamfi-Bannerman C; Ananth CV
    BJOG; 2015 Apr; 122(5):712-8. PubMed ID: 25428801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.
    Conde-Agudelo A; Romero R
    Am J Obstet Gynecol; 2016 Feb; 214(2):235-242. PubMed ID: 26450404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
    Cheung KW; Seto MTY; Ng EHY
    Trials; 2020 Jan; 21(1):121. PubMed ID: 32000820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of progesterone on cervical shortening in women at risk for preterm birth: secondary analysis from a multinational, randomized, double-blind, placebo-controlled trial.
    O'Brien JM; Defranco EA; Adair CD; Lewis DF; Hall DR; How H; Bsharat M; Creasy GW;
    Ultrasound Obstet Gynecol; 2009 Dec; 34(6):653-9. PubMed ID: 19918965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of universal screening for preterm delivery by mid-trimester cervical-length measurement.
    Souka AP; Papastefanou I; Pilalis A; Kassanos D; Papadopoulos G
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):396-401. PubMed ID: 29536576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in cervical length after vaginal progesterone in women with short cervix is significantly associated with preterm delivery at ≤ 34 weeks and < 37 weeks of gestation.
    Hernandez-Andrade E; Huntley ES; Sibai B; Blackwell SC; Soto-Torres EE
    Ultrasound Obstet Gynecol; 2024 May; 63(5):644-649. PubMed ID: 37916641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis.
    Klein K; Rode L; Nicolaides KH; Krampl-Bettelheim E; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):281-7. PubMed ID: 21739499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pessary Compared With Vaginal Progesterone for the Prevention of Preterm Birth in Women With Twin Pregnancies and Cervical Length Less Than 38 mm: A Randomized Controlled Trial.
    Dang VQ; Nguyen LK; Pham TD; He YTN; Vu KN; Phan MTN; Le TQ; Le CH; Vuong LN; Mol BW
    Obstet Gynecol; 2019 Mar; 133(3):459-467. PubMed ID: 30741812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.